Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech graveyard
Biotech
Caribou’s ‘heartbreaking’ call to lay off staff, halt pipeline
The Bay Area biotech is discontinuing all clinical development activities and implementing a "substantial reduction in workforce."
Darren Incorvaia
Oct 7, 2026 5:00am
Adecto blames ‘risk-adverse funding environment’ for closing
Oct 2, 2026 3:53am
Arpeggio Bio disbands after Nrf2 program starts to ‘unravel’
Aug 10, 2026 5:04am
Biopharma layoffs maintain slowdown in Q1
Apr 1, 2026 8:42am
Fierce Pharma
Iterum initiates wind-down after failure to offload antibiotic
Mar 31, 2026 2:06pm
After FDA refusal, IO Biotech surrenders to bankruptcy
Mar 31, 2026 10:17am